Tokyo, Oct. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059424) titled 'Development of a Novel CAR-T Therapy Targeting Translational Dysfunction in Exhausted T Cells' on Oct. 25.
Study Type:
Observational
Primary Sponsor:
Institute - Tohoku University
Condition:
Condition - Lung Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to develop a novel CAR-T cell therapy that restores the antitumor activity of T cells through the regulation of protein translation, with a particular focus on tRNA modifications and ribosomal function.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
= 2...